Research topic: In collaboration with Marseille Medical Genetics laboratory, we will develop novel cellular models derived from hiPSCs and assess the efficacy of therapeutic strategies targeting nonsense mutations in the LAMA2 gene, encoding laminin alpha2 chain. LAMA2-related disorders are among the most common form of congenital muscular dystrophy in Europe.
